Browse: Companies | People | Financial Organizations
Home > Companies > Genmab

General Information

Websitegenmab.com
CategoryBioTech
Phone+ 45 7020 2728
Email
Employees

Offices

Copenhagen K , DNK
Bredgade 34
Copenhagen K , 1260, DNK

Funding

Unattributed, 10/09
GlaxoSmithKline
$23M

Tags

Genmab

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Genmab’s world class discovery, development and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs. Our primary goal is to improve the lives of patients who are in urgent need of new treatment options.

Milestones

  • Dollar
    Genmab received $23M in Unattributed funding. (10/09)
    Posted 10/27/09 at 11:29pm

Videos

Screenshots

Sources

  1. Genmab wins $23M on blockbuster cancer approval (fiercebiotech.com) [edit]
Edit This Page
Last Edited 10/27/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy